Edition:
United States

Olympus Corp (7733.T)

7733.T on Tokyo Stock Exchange

4,435JPY
2:00am EDT
Change (% chg)

¥-10 (-0.22%)
Prev Close
¥4,445
Open
¥4,430
Day's High
¥4,435
Day's Low
¥4,405
Volume
936,400
Avg. Vol
1,201,401
52-wk High
¥4,660
52-wk Low
¥3,600

Chart for

About

Olympus Corporation is engaged in the manufacture and sale of precision machineries and instruments. The Company's segments include Medical Business, Scientific Solutions Business, Imaging Business and Others. The Company's Medical Business manufactures and sells medical endoscopes, surgical endoscopes, endotherapy devices and... (more)

Overall

Beta: 1.06
Market Cap(Mil.): ¥1,511,302.00
Shares Outstanding(Mil.): 342.69
Dividend: --
Yield (%): 0.63

Financials

  7733.T Industry Sector
P/E (TTM): 26.66 37.52 33.34
EPS (TTM): 166.73 -- --
ROI: 8.50 8.76 13.18
ROE: 13.63 12.58 15.09

Activist investor ValueAct has $612 million stake in Japan's Olympus

TOKYO U.S. hedge fund ValueAct Capital has become a major shareholder in Japanese medical equipment and camera maker Olympus Corp with a 5.04 percent stake that is worth around $612 million at current shares prices.

May 31 2018

UPDATE 2-Activist investor ValueAct has $612 mln stake in Japan's Olympus

* ValueAct says bought Olympus shares as investment (Adds ValueAct statement)

May 31 2018

U.S. hedge fund ValueAct has 5 pct stake in Japan's Olympus

TOKYO, May 31 U.S. hedge fund ValueAct Capital has become a major shareholder in Japanese medical equipment and camera maker Olympus Corp with a 5.04 percent stake, a regulatory filing showed on Thursday.

May 31 2018

BRIEF-Urogen Pharma Announces Positive Interim Results From Pivotal Phase 3 Olympus Trial Of UGN-101

* UROGEN PHARMA ANNOUNCES POSITIVE INTERIM RESULTS FROM PIVOTAL PHASE 3 OLYMPUS TRIAL OF UGN-101 (MITOGEL™) FOR NON-SURGICAL TREATMENT OF UPPER TRACT UROTHELIAL CANCER (UTUC)

May 21 2018

BRIEF-Olympus says unit Olympus (Shenzhen) Industrial suspends operation

* Says its unit Olympus (Shenzhen) Industrial Ltd., suspends operation on May 7

May 07 2018

BRIEF-Olympus Announces Intention To Acquire Lithotripsy Systems From Cybersonics

* OLYMPUS ANNOUNCES INTENTION TO ACQUIRE LITHOTRIPSY SYSTEMS FROM CYBERSONICS, INC. Source text for Eikon:

Apr 10 2018

BRIEF-U.S. FDA Issues Warning Letters To Duodenoscope Manufacturers, Olympus, Fujifilm And Pentax

* U.S. FDA SAYS ISSUED WARNING LETTERS TO DUODENOSCOPE MANUFACTURERS, OLYMPUS, FUJIFILM, PENTAX FOR FAILING TO COMPLY WITH REQUIREMENTS OF FEDERAL LAW

Mar 09 2018

Earnings vs. Estimates